Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06680050 |
| Title | Phase II Study of Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen (AUSTRAL) (AUSTRAL) |
| Acronym | AUSTRAL |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Mario Negri Institute for Pharmacological Research |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| ASST degli Spedali Civili di Brescia | Brescia | Italy | Details | |||
| Azienda Ospedaliero Universitaria Careggi | Firenze | Italy | Details | |||
| IRCCS Ospedale Policlinico San Martino, Genova | Genova | Italy | Details | |||
| ASST Grande Ospedale Metropolitano Niguarda | Milan | Italy | Details | |||
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | Italy | Details | |||
| Azienda ospedaliera di Padova | Padova | Italy | Details | |||
| Azienda Ospedaliero - Universitaria di Parma | Parma | Italy | Details | |||
| University Hospital of Geneva | Geneva | Switzerland | Details | |||
| University Hospital Zurich | Zürich | Switzerland | Details |